BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4916023)

  • 1. Vincristine therapy of lymphomas and chronic lymphocytic leukemia.
    Desal DV; Ezdinli EZ; Stutzman L
    Cancer; 1970 Aug; 26(2):352-9. PubMed ID: 4916023
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effectiveness of polychemotherapeutic treatments of lymphoproliferative diseases].
    Cajozzo A; Citarrella P; Carreca I; D'Eredità F
    Haematologica; 1970; 55(7):465-70. PubMed ID: 4996520
    [No Abstract]   [Full Text] [Related]  

  • 3. [Personal experience on the chemotherapy of leukemias and hematosarcomas].
    Mathé G; Schneider M; Schwarzenberg L; Cattan A; Amiel JL; Schlumberger JR
    Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):245-54. PubMed ID: 4874537
    [No Abstract]   [Full Text] [Related]  

  • 4. Vincristine neuropathy. Clinical and electrophysiological observations.
    Casey EB; Jellife AM; Le Quesne PM; Millett YL
    Brain; 1973; 96(1):69-86. PubMed ID: 4348690
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical and physiopathological effects of Vincristine on the nervous system].
    Freund HJ; Kendel K; Obrecht P
    Dtsch Z Nervenheilkd; 1969 Oct; 196(4):319-30. PubMed ID: 4899921
    [No Abstract]   [Full Text] [Related]  

  • 6. Corticosteroid therapy for lymphomas and chronic lymphocytic leukemia.
    Ezdinli EZ; Stutzman L; Aungst CW; Firat D
    Cancer; 1969 Apr; 23(4):900-9. PubMed ID: 4887296
    [No Abstract]   [Full Text] [Related]  

  • 7. [Methylhydrazine in the therapy of malignant lymphopathies].
    Beltrametti L; Almici C
    Policlinico Prat; 1967 Jan; 74(3):82-5. PubMed ID: 4878309
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of two alkaloids derived from Vinca rosea on the malignant cells of Hodgkin's disease, lymphosarcoma and acute leukemia in vivo.
    Marmont AM; Damasio EE
    Blood; 1967 Jan; 29(1):1-21. PubMed ID: 5334796
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of malignant lymphomas with bleomycin.
    Kimura I; Onoshi T; Kunimasa I; Takano J
    Cancer; 1972 Jan; 29(1):58-60. PubMed ID: 4109085
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination chemotherapy of lymphomas other than Hodgkin's disease.
    Stein RS; Moran EM; Desser RK; Miller JB; Golomb HM; Ultmann JE
    Ann Intern Med; 1974 Nov; 81(5):601-8. PubMed ID: 4608355
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotherapy of the lymphomas.
    Lacher MJ
    Med Times; 1970 May; 98(5):96-102. PubMed ID: 4911076
    [No Abstract]   [Full Text] [Related]  

  • 12. A kinetically designed chemotherapeutic regimen for advanced refractory lymphoma patients.
    Rossof AH; Kerr RO; Braine HG; Coltman CA
    Med Pediatr Oncol; 1978; 4(2):133-9. PubMed ID: 78437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose corticoid therapy in Hodgkin's disease and other lymphomas.
    Hall TC; Choi OS; Abadi A; Krant MJ
    Ann Intern Med; 1967 Jun; 66(6):1144-53. PubMed ID: 5338940
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent advances in chemotherapy of lymphoma.
    Lenhard RE; Owens AH
    Johns Hopkins Med J; 1967 Aug; 121(2):136-40. PubMed ID: 5340335
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical results of treatment with E. coli L-asparaginase in adults with leukemia, lymphoma, and solid tumors.
    Clarkson B; Krakoff I; Burchenal J; Karnofsky D; Golbey R; Dowling M; Oettgen H; Lipton A
    Cancer; 1970 Feb; 25(2):279-305. PubMed ID: 4905154
    [No Abstract]   [Full Text] [Related]  

  • 16. Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomas.
    Mathé G; Schwarzenberg L; Pouillart P; Oldham R; Weiner R; Jasmin C; Rosenfeld C; Hayat M; Misset JL; Musset M; Schneider M; Amiel JL; De Vassal F
    Cancer; 1974 Oct; 34(4):985-92. PubMed ID: 4608026
    [No Abstract]   [Full Text] [Related]  

  • 17. [Leukaemias and lymphomas treatment by vindesine. Result of a phase II trial in terms of remission induction (author's transl)].
    Marthé G; Misset JL; de Vassal F; Hayat M; Gouveia J; Machover D; Belpomme D; Schwarzenberg L; Ribaud P; Pico JL; Musset M; Jasmin C; de Luca L
    Nouv Presse Med; 1978 Feb; 7(7):525-8. PubMed ID: 273888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of malignant lymphomas with methyl ester of streptonigrin (NSC 45384).
    Rivers SL; Whittington RM; Medrek TJ
    Cancer; 1966 Oct; 19(10):1377-85. PubMed ID: 5337271
    [No Abstract]   [Full Text] [Related]  

  • 19. Leukemia and lymphoma.
    White LP
    Geriatrics; 1970 Dec; 25(12):82-6. PubMed ID: 5274229
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic progress and iatrogenic problems in malignant hemopathies].
    Geib KR; Papazian R
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1977; 29(4):343-9. PubMed ID: 22916
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.